12 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
and Management ... PCR is gold standard ... Chronic disease is ... #Management #Microbiology ... #InfectiousDiseases
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... and HPV test) is ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
and Management ... non-toxigenic • Stool PCR ... (IDSA 2021): ... Note: Fidaxomicin is ... #infectiousdiseases
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
and Management ... PCR is gold standard ... Chronic disease is ... #Management #Microbiology ... #InfectiousDiseases
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
whose positive charges ... whose positive charges ... #criticalcare #management ... #diagnosis #treatment ... #pharmacology #
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... KaposiSarcoma #Castlemans #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... every 3 months) is ... Pneumocystis #Pneumonia #IDSA ... opportunistic #infections #HIVAIDS ... #management #pharmacology